Back

Prevalence and determinants of atrial fibrillation progression in women and men with paroxysmal atrial fibrillation - discussion.

4 April 2022 (19:10 - 19:15)
Organised by:
Congress Presentation Part of: Late Breaking Clinical Trials II - atrial fibrillation, news on ablation and sex differences Arrhythmias, General EHRA Premium Access EHRA 2022

7 More presentations in this session

Presentation thumbnail
Sex differences in early rhythm control therapy in atrial fibrillation
Slides Video
Presentation thumbnail
Sex differences in early rhythm control therapy in atrial fibrillation - discussion.
Video
Presentation thumbnail
MANIFEST-PF: multi-national survey on methods, efficacy and safety on the post-approval clinical use of pulsed field ablation
Slides Video
Presentation thumbnail
MANIFEST-PF - discussion.
Video
Presentation thumbnail
High radiofrequency power for faster and safer pulmonary vein ablation trial (POWER FAST III)
Slides Video

Access the full session

Session thumbnail
Late Breaking Clinical Trials II - atrial fibrillation, news on ablation and sex differences
Video

The Event

Event poster

EHRA 2022

4 April 2022 19:10 CET
You may be interested in
thumbnail
Congress Presentation
Atrial fibrillation progression and healthcare burden: data from the RACE V study
30 August 2025
thumbnail
Congress Presentation
Do we need trials to account for sex differences in HFpEF?
24 May 2022
thumbnail
Congress Presentation
Female sex-related stroke risk in atrial fibrillation: a thing from the past?
12 April 2026
thumbnail
Congress Presentation
Sex-based differences in bi-atrial structure, function, and electrophysiology in atrial fibrillation
12 April 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources